Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management and outcomes of men diagnosed with primary breast cancer.
Johnson AE, Coopey SB, Spring LM, Horick NK, Leone JP, Lin NU, Dominici LS, Hughes KS, Jimenez RB. Johnson AE, et al. Among authors: horick nk. Breast Cancer Res Treat. 2021 Jul;188(2):561-569. doi: 10.1007/s10549-021-06174-y. Epub 2021 Apr 8. Breast Cancer Res Treat. 2021. PMID: 33830393
Cording following treatment for breast cancer.
O'Toole J, Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, Elliott K, Niemierko A, Taghian AG. O'Toole J, et al. Breast Cancer Res Treat. 2013 Jul;140(1):105-11. doi: 10.1007/s10549-013-2616-9. Epub 2013 Jun 29. Breast Cancer Res Treat. 2013. PMID: 23813304 Free PMC article. Clinical Trial.
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG. Specht MC, et al. Breast Cancer Res Treat. 2013 Aug;140(3):485-94. doi: 10.1007/s10549-013-2655-2. Epub 2013 Aug 4. Breast Cancer Res Treat. 2013. PMID: 23912961 Free PMC article. Clinical Trial.
Long-term risk of medical conditions associated with breast cancer treatment.
Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM. Hill DA, et al. Among authors: horick nk. Breast Cancer Res Treat. 2014 May;145(1):233-43. doi: 10.1007/s10549-014-2928-4. Epub 2014 Apr 3. Breast Cancer Res Treat. 2014. PMID: 24696430 Free PMC article.
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE. Strasser-Weippl K, et al. Breast Cancer Res. 2015 Apr 16;17(1):56. doi: 10.1186/s13058-015-0568-1. Breast Cancer Res. 2015. PMID: 25888246 Free PMC article.
132 results